What are the obligations of pharmaceutical companies in a global health emergency?

by Emanuel, EJ, Buchanan, A, Chan, SY, Fabre, C, Halliday, D, Heath, J, Herzog, L, Leland, RJ, McCoy, MS, Norheim, OF, Saenz, C, Schaefer, GO, Tan, KC, Wellman, CH, Wolff, J, Persad, G
Published 2022

Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability

by Moon, S, Armstrong, J, Hutler, B, Upshur, R, Katz, R, Atuire, C, Bhan, A, Emanuel, E, Faden, R, Ghimire, P, Greco, D, Ho, CW, Kochhar, S, Schaefer, GO, Shamsi-Gooshki, E, Singh, JA, Smith, MJ, Wolff, J
Published 2022